- Home
- FCAP vs DERM Comparison
FCAP vs DERM Comparison
Compare FCAP & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCAP
- DERM
- Stock Information
- Founded
- FCAP 1891
- DERM 2014
- Country
- FCAP United States
- DERM United States
- Employees
- FCAP N/A
- DERM N/A
- Industry
- FCAP Savings Institutions
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- FCAP Finance
- DERM Health Care
- Exchange
- FCAP Nasdaq
- DERM Nasdaq
- Market Cap
- FCAP 161.2M
- DERM 181.0M
- IPO Year
- FCAP 1999
- DERM 2021
- Fundamental
- Price
- FCAP $49.00
- DERM $7.94
- Analyst Decision
- FCAP
- DERM Strong Buy
- Analyst Count
- FCAP 0
- DERM 2
- Target Price
- FCAP N/A
- DERM $10.00
- AVG Volume (30 Days)
- FCAP 10.6K
- DERM 103.3K
- Earning Date
- FCAP 07-25-2025
- DERM 05-14-2025
- Dividend Yield
- FCAP 2.36%
- DERM N/A
- EPS Growth
- FCAP 2.61
- DERM N/A
- EPS
- FCAP 3.65
- DERM N/A
- Revenue
- FCAP $42,869,000.00
- DERM $56,243,000.00
- Revenue This Year
- FCAP N/A
- DERM $29.83
- Revenue Next Year
- FCAP N/A
- DERM $54.88
- P/E Ratio
- FCAP $13.45
- DERM N/A
- Revenue Growth
- FCAP 6.35
- DERM N/A
- 52 Week Low
- FCAP $27.10
- DERM $3.54
- 52 Week High
- FCAP $53.85
- DERM $8.24
- Technical
- Relative Strength Index (RSI)
- FCAP 56.97
- DERM 63.48
- Support Level
- FCAP $48.50
- DERM $6.55
- Resistance Level
- FCAP $50.50
- DERM $7.00
- Average True Range (ATR)
- FCAP 1.05
- DERM 0.64
- MACD
- FCAP -0.24
- DERM 0.12
- Stochastic Oscillator
- FCAP 50.42
- DERM 87.02
About FCAP First Capital Inc.
First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.